Why the study?
Does transdermal nicotine alter autonomic regulation (RR interval and SAP variability) compared to placebo or cigarette smoking in heavy smokers?
Population
27 heavy smokers, mean age 43 +/- 2 years
Comparison
Transdermal nicotine and cigarette smoking vs Placebo
Design
RCT, double-blind
Authors
Loading...
Supports nicotine patch use in smoking cessation without autonomic concerns; confirms lack of significant sympathomimetic effects versus placebo.
Does transdermal nicotine alter autonomic regulation (RR interval and SAP variability) compared to placebo or cigarette smoking in heavy smokers?
Nicotine patches do not cause significant sympathomimetic autonomic disturbances compared to placebo, supporting their cardiovascular safety in smoking cessation.
Lucini et al. (1998) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: